Table 3.
Sensitivity analysis | CRC incidence disparity % explained by screening | CRC mortality disparity | ||
---|---|---|---|---|
% explained by screening | % explained by survival | % explained by screening and survival* | ||
Base case analysis | 42% | 19% | 36% | 54% |
Lower-quality endoscopy in blacks | 68% | 34% | 36% | 66% |
25% remaining survival difference | 42% | 19% | 28% | 46% |
Same stage distribution as whites | 42% | 19% | 57% | 60% |
Because of synergy in effects separate effects of screening and survival do not add up.